Evidence map›Paper›PMID 36671219›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Redo DAIR: The Game Is Seldom Worth the Candle.

Ignacio Sancho, Iñaki Otermin-Maya, Jorge Gutiérrez-Dubois, Ignacio Aláez, Julián Librero, Maria Eugenia Portillo, Ángel Hidalgo-Ovejero

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ignacio SanchoDepartment of Orthopaedics and Trauma Surgery, Hospital Reina Sofía, 31500 Tudela, Spain.ORCID 0000-0002-1077-0354
Iñaki Otermin-MayaDepartment of Internal Medicine, Hospital Universitario de Navarra, 31008 Pamplona, Spain.
Jorge Gutiérrez-DuboisDepartment of Internal Medicine, Hospital Universitario de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-9364-2031
Ignacio AláezDepartment of Internal Medicine, Hospital Universitario de Navarra, 31008 Pamplona, Spain.
Julián LibreroInstituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
Maria Eugenia PortilloInstituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0002-4167-3645
Ángel Hidalgo-OvejeroDepartment of Orthopaedics and Trauma Surgery, Hospital Universitario de Navarra, 31008 Pamplona, Spain.
Universidad de Navarra · ESComplejo Hospitalario de Navarra · ESNavarre Institute of Health Research · ESUniversidad Publica de Navarra · ES

Funding

Navarra Biomed (NB) - Servicio Navarro de Salud-Osasunbidea (SNS-O)
6 · The paper itself

Abstract

Debridement, antibiotics and implant retention (DAIR) remains a commonly utilized technique in the treatment of acute prosthetic joint infections despite its inconsistent outcomes. The performance of a second DAIR after a failed first debridement is controversial as outcomes are uncertain and the final prognosis in the event of failure may be unfavorable. This study analyzes 84 cases of acute prosthetic (hip & knee) joint infection treated with DAIR between 2011 and 2020 at the same institution. In 12 failed cases, a second DAIR was performed, whose success rate was significantly lower than that of the first procedure (8% [95% CI, 0-38] vs. 57% [46-68]). Moreover, the ultimate outcome of the second failed DAIRs was unfavorable with eradication of the infection being achieved in none of the patients. Due to the high likelihood of failure and the potentially grim final prognosis following a second debridement, removal of the components should be considered.

Indexed as

multiple debridementsprosthetic joint infectionsecond DAIR

Identifiers

PMID36671219
PMCPMC9854634
OpenAlexW4313415339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.